Astaxanthin protects against hearing impairment in diabetic rats

被引:2
|
作者
Toprak, Serdar Ferit [1 ]
Dedeoglu, Serkan [2 ]
机构
[1] Dicle Univ, Dept Otorhinolaryngol, Fac Med, Diyarbakir, Turkey
[2] Gazi Yasargil Training & Res Hosp, Dept Otorhinolaryngol, Diyarbakir, Turkey
关键词
Diabetes mellitus; Astaxanthin; Hearing loss; Pro-inflammatory; cytokines; OXIDATIVE STRESS; INDUCED OTOTOXICITY; MELLITUS; MECHANISMS;
D O I
10.1016/j.bjorl.2022.02.004
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: Diabetes Mellitus (DM) causes an increase in oxidative stress that leads to deterioration in auditory functions. Astaxanthine (AST) is known to have strong antioxidant effects. In this study, the aim is to investigate the effect of AST against hearing loss that is due to DM. Methods: This study is an experimental animal study. The study was designed in four groups with 8 animals (n = 8) in each group. The groups were as follows; Control Group (CNT), Diabetic Group (DM), AST applied diabetic group (DM+AST), and AST applied non-diabetic group (AST). Streptozotocin was applied in rats to induce DM. AST was administered by oral gavage. Auditory Brainstem Responses (ABR) and Distortion Product Otoacoustic Emissions (DPOAE) tests were performed on several days of the study. At the end of the study, pro-inflammatory cytokine levels were analyzed in cochlear tissue samples, and Glutathione Peroxidase (GPx), Superoxide Dismutase (SOD), Catalase (CAT) and Malondialdehyde (MDA) levels were measured. Results: When the findings obtained in the ABR and DPOAE tests in the DM group, it was observed that there was a significant deterioration in the hearing sense. This deterioration was not observed in the DM+AST group. In the DM group, GPx, SOD and CAT levels decreased and MDA levels increased in blood and cochlear tissue. Compared to the DM group, it was noted that antioxidant enzyme levels increased and MDA levels decreased in the DM+AST group. Cochlear tissue pro-inflammatory cytokine levels, which increased with DM, were significantly decreased in the DM+AST group. Conclusion: Even though the effects of AST were investigated in a diabetic experimental animal model, if this molecule is proven to be effective in diabetic humans, it can be considered an adjunct therapeutic option with its antioxidant effects. Level of evidence: The level of evidence of this article is 5. This article is an experimental animal and laboratory study. (c) 2022 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:S73 / S80
页数:8
相关论文
共 50 条
  • [1] Astaxanthin protects β-cells against glucose toxicity in diabetic db/db mice
    Uchiyama, K
    Naito, Y
    Hasegawa, G
    Nakamura, N
    Takahashi, J
    Yoshikawa, T
    [J]. REDOX REPORT, 2002, 7 (05) : 290 - 293
  • [2] Erythropoietin Protects Against Cognitive Impairment and Hippocampal Neurodegeneration in Diabetic Mice
    Othman, Manal A. M.
    Rajab, Ebrahim
    AlMubarak, Ahmed
    AlNaisar, Mohammed
    Bahzad, Noora
    Kamal, Amer
    [J]. BEHAVIORAL SCIENCES, 2019, 9 (01)
  • [3] Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
    Liu, Wenjuan
    Gong, Wei
    He, Min
    Liu, Yemei
    Yang, Yeping
    Wang, Meng
    Wu, Meng
    Guo, Shizhe
    Yu, Yifei
    Wang, Xuanchun
    Sun, Fei
    Li, Yiming
    Zhou, Linuo
    Qin, Shengmei
    Zhang, Zhaoyun
    [J]. JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [4] Clematis chinensis Extract Protects against Diabetic Nephropathy in Rats
    Xu, Liang
    Zhao, Bing
    Sun, Jing
    Wang, Hai-ping
    Wang, Rong
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (03) : 513 - 519
  • [5] Maintenance of mitochondrial function by astaxanthin protects against bisphenol A-induced kidney toxicity in rats
    Jiang, Wei
    Zhao, Hu
    Zhang, Lijin
    Wu, Bin
    Zha, Zhenlei
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
  • [6] Sulpiride increases intraocular vasoinhibin and protects against diabetic retinopathy in rats
    Adan Castro, Elva Hortencia
    Ramirez-Hernandez, Gabriela
    Diaz-Lezama, Nundehui
    Montserrat Siqueiros, Lourdes
    Granados-Carrasco, Daniela
    Ruiz-Herrera, Xarubeth
    Lopez-Barrera, Fernando
    Robles-Osorio, Ludivina
    de la Escalera, Gonzalo Martinez
    Clapp, Carmen
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [7] Agmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic rats
    Bhutada, Pravinkumar
    Mundhada, Yogita
    Humane, Vishwas
    Rahigude, Anand
    Deshmukh, Prashant
    Latad, Sandeep
    Jain, Kishor
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 37 (01): : 96 - 105
  • [8] Anticoagulatory and Antiinflammatory Effects of Astaxanthin in Diabetic Rats
    Chan, Kung-chi
    Pen, Pei-Jain
    Yin, Mei-chin
    [J]. JOURNAL OF FOOD SCIENCE, 2012, 77 (02) : H76 - H80
  • [9] Protective effects of astaxanthin on diabetic cardiomyopathy in rats
    Zhang, Bingshan
    Xu, Di
    [J]. CYTA-JOURNAL OF FOOD, 2018, 16 (01) : 909 - 915
  • [10] Pyrrolidine dithiocarbamate protects against scopolamine-induced cognitive impairment in rats
    Abd-El-Fattah, Mai A.
    Abdelakader, Noha F.
    Zaki, Hala F.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723 : 330 - 338